Overview

Montelukast as a Controller of Atopic Syndrome

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out if montelukast can be used to treat the various symptoms of allergic syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University
University of Helsinki
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast